Skip to main content
VCbacked
Log inGet Started

Onchilles Pharma

San Diego, United States

Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.

$25.0M raised
Nov 2025
Series A
BiopharmaBiotechnologyPharmaceutical

Top Investors

Kennedy Lewis Investment ManagementLYZZ CapitalLincoln Park Capital FundInVivium CapitalPolsky Center at the University of Chicago

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Onchilles Pharma

How much funding has Onchilles Pharma raised?
Onchilles Pharma has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
Who are Onchilles Pharma's investors?
Onchilles Pharma's investors include Kennedy Lewis Investment Management, LYZZ Capital, Lincoln Park Capital Fund, InVivium Capital, Polsky Center at the University of Chicago.
Where is Onchilles Pharma headquartered?
Onchilles Pharma is headquartered in San Diego, United States.
What does Onchilles Pharma do?
Onchilles Pharma is a biotechnology company developing first-in-class biologics therapies for the treatment of cancer.
What stage is Onchilles Pharma at?
Onchilles Pharma is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Onchilles Pharma — Funding & Investors." VCBacked, November 7, 2025, https://www.vcbacked.co/company/onchilles-pharma. Accessed June 17, 2026.
APA
VCBacked. (2025). Onchilles Pharma — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/onchilles-pharma
Wikipedia (cite web)
{{cite web |title=Onchilles Pharma — Funding & Investors |url=https://www.vcbacked.co/company/onchilles-pharma |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego